| Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637) |
|---|
| 08/07/2003 | WO2003064443A2 New corticosteroids |
| 08/07/2003 | US20030149287 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds |
| 08/07/2003 | CA2473249A1 New corticosteroids |
| 07/30/2003 | EP1135403B1 17beta-acyl-17alpha-propynyl-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/30/2003 | CN1433424A 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 07/29/2003 | CA2098804C Process for the preparation of a delta 9(11) steroid compound |
| 07/24/2003 | US20030139385 Method of treating disorder related to high cholesterol concentration |
| 07/23/2003 | EP1328538A1 Process and intermediates for the production of 7-substituted antiestrogens |
| 07/22/2003 | US6596885 19-Nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and compositions |
| 07/22/2003 | US6596713 Antigestagenic, antiglucocorticoidal, antimineralcorticoidal or antiandrogenic effect |
| 07/17/2003 | US20030134834 Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain |
| 07/17/2003 | US20030134829 X is a ring having at least 4 atoms in the ring; K is hydrocarbyl group; Rh1 is an optional halo group; Rh2 is an optional halo group; at least one of Rh1 and Rh2 is present; Rs is any one of a sulphamate group, a phosphonate, |
| 07/16/2003 | CN1430625A 3-nitrogen-6,7-dioxygen steroids and uses thereof |
| 07/16/2003 | CN1430624A Novel solid body forms of mesoprogestin 11-beta-[4E-(hydroxyimino methyl)-phenyl]-17-alpha-methoxy methyl-17 beta-methoxy-estra-4,9-dien-3-one |
| 07/16/2003 | CN1430600A 7-and 9-carbamate, urea, thiourea, thiocarbamate and heteroaryl-amino substituted tetracycline compounds |
| 07/10/2003 | US20030130246 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 07/09/2003 | EP1325928A1 Process for the preparation of pregnane derivatives |
| 07/09/2003 | CN1429104A Inhibitors type 5 and type 3 17 beta-hydroxysteroid dehydrogenase and methods for their use |
| 07/08/2003 | US6589946 Bile salt conjugates |
| 07/03/2003 | WO2003053992A2 Industrially applicable process for the sulfamoylation of alcohols and phenols |
| 07/03/2003 | WO2003053365A2 Syn3 compositions and methods |
| 07/03/2003 | WO2002094849A3 Process for the production of 6, 7 - dihydroxy steroid compounds by allylic oxidation of steroid - 5 - ene compounds to steroid - 5 - ene - 7 - one compounds followed by hydroboration and oxidation and intermediates of this process |
| 07/03/2003 | CA2470999A1 Syn3 compositions and methods |
| 07/02/2003 | EP1322662A1 19-nor-17 alpha-pregna-1,3,5 (10)-trien-17 beta-ols of a 21,16 alpha-lactone ring |
| 07/01/2003 | CA2089194C Steroid derivatives |
| 06/24/2003 | US6583130 C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds |
| 06/19/2003 | WO2003039480A3 Method of treating disorder related to high cholesterol concentration |
| 06/19/2003 | US20030113361 Palatable arginine compounds and uses thereof for cardiovascular health |
| 06/19/2003 | US20030113265 Contrast agents for magnetic resonance imaging |
| 06/17/2003 | US6579864 Arthritic diseases and/or autoimmune diseases |
| 06/17/2003 | CA2096020C 2.beta.,19-methyleneamino bridged steroids as aromatase inhibitors |
| 06/12/2003 | WO2003047549A2 Post-coated liposome/lipoplex for targeted drug/gene delivery and lipid linked to a delivery, targeting or stabilising moiety |
| 06/12/2003 | US20030109520 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 06/12/2003 | CA2465455A1 Compound |
| 06/11/2003 | EP1317439A1 Acid-sensitive compounds, preparation and uses thereof |
| 06/05/2003 | WO2003045972A1 17α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATES FOR THE PRODUCTION THEREOF, AND USE OF SAID 17α-ALKYL-17β-OXY-ESTRATRIENES FOR PRODUCING MEDICAMENTS AND PHARMACEUTICAL PREPARATIONS |
| 06/05/2003 | US20030104360 Synthetic receptors, libraries and uses thereof |
| 05/28/2003 | CN1420891A Pharmaceutical compound |
| 05/27/2003 | US6569844 Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives |
| 05/27/2003 | US6569411 Deodoring, microbiocides, marking odors |
| 05/22/2003 | US20030097011 Novel carbamate-based cationic lipids |
| 05/22/2003 | US20030096800 Estrogenic compounds as anti-mitotic agents |
| 05/21/2003 | EP1311534A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds |
| 05/21/2003 | EP1311533A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 05/21/2003 | EP1311532A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 05/21/2003 | EP1311531A1 Steroid derived antibiotics |
| 05/21/2003 | EP0942919B1 Sulphatase Inhibitors |
| 05/20/2003 | US6566542 Such as 17-alpha-fluoro-11-beta-(4-(2-(1-piperidinyl) ethoxy) phenyl)-estra-1,3,5(10)-trien-3-ol for treatment of osteoporosis and cardiovascular protection; side effect reduction; provides alternative to estradiol |
| 05/15/2003 | WO2003039480A2 Method of treating disorder related to high cholesterol concentration |
| 05/15/2003 | CA2466033A1 Method of treating disorder related to high cholesterol concentration |
| 05/14/2003 | EP1310509A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 05/14/2003 | EP1310508A2 Estrogen sulfamate sulphatase inhibitors |
| 05/14/2003 | EP1165595B1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486 |
| 05/14/2003 | EP0830369B1 Nor-pregnanes for inducing hypothalamic effects |
| 05/08/2003 | WO2003038523A2 Polycarbocyclic derivatives for modification of resist, optical and etch resistance properties |
| 05/08/2003 | US20030087887 Gonane derivative antibiotics |
| 05/02/2003 | EP0811006B1 Benzopyran-containing compounds and method for their use |
| 04/24/2003 | WO2002066490A3 Cationic sterol derivatives, ph-sensitive liposomes comprising cationic sterol derivatives and method for loading liposomes with active substances |
| 04/23/2003 | EP1304334A1 Novel antiandrogenic agent |
| 04/23/2003 | EP1304333A2 6,7-Oxygenated steroids and uses related thereto |
| 04/22/2003 | US6552011 (Androst-5-en-17beta -yl)alkyl sulfoxides and sulfones and their use for control of fertility |
| 04/17/2003 | US20030073675 Novel 19-norsteroids substituted in position 11beta, preparation process and intermediates, application as medicines and pharmaceutical compositions containing them |
| 04/17/2003 | US20030073640 Novel compositions for the delivery of negatively charged molecules |
| 04/16/2003 | EP1301212A1 Pharmaceutically active compound |
| 04/16/2003 | EP1090027B1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 04/16/2003 | EP1060187B1 S-substituted 11beta-benzaldoxime-estra-4,9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds |
| 04/15/2003 | US6548491 Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 04/15/2003 | CA2130516C New 11-benzaldoxime-estradiene derivatives, processes for their production and pharmaceuticals containing these substances |
| 04/15/2003 | CA2084775C Method of treating human prostatic adenocarcinoma |
| 04/15/2003 | CA2048242C 4-amino-4-steroids and their use as 5.alpha.-reductase inhibitors |
| 04/10/2003 | WO2003020214A3 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 04/10/2003 | WO2002094942A9 Method of purifying polycyclic dyes |
| 04/10/2003 | US20030069434 Antiestrogenic properties or tissue-selective estrogenic properties |
| 04/09/2003 | EP1299409A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 04/08/2003 | CA2084431C 17-spirofuran-3'-ylidene steroids |
| 04/08/2003 | CA2048243C 4-amino- 4,6-steroids and their use as 5-.alpha.-reductase inhibitors |
| 04/03/2003 | WO2003027132A2 METHOD OF PREPARING 17β-(N-TERT-BUTYLCARBAMOYL)-3-ONE STEROID DERIVATIVES |
| 04/03/2003 | WO2003026568A2 Androstanes as androgen receptor modulators |
| 04/03/2003 | US20030064973 Sexual disorders |
| 04/03/2003 | CA2459943A1 Androstanes as androgen receptor modulators |
| 04/02/2003 | EP1124841B1 Substituted phenyl alkenoyl guanidines, method for the production thereof, use thereof as medicaments or diagnostic agents and medicaments that contain them |
| 04/02/2003 | EP0738157B1 Contrast media for x-ray and magnetic resonance imaging |
| 04/01/2003 | US6541464 For therapy of osteoporosis |
| 04/01/2003 | US6541463 Inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase and methods for their use |
| 03/27/2003 | US20030060646 Process for preparing17alpha-acetoxy-11beta-[4-n,n(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene -3,20-dione, intermediates useful in the process , and processes for preparing such intermediates |
| 03/26/2003 | EP1294402A2 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 03/20/2003 | US20030055274 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 03/20/2003 | US20030055029 Combbretastatin a-4 as an anti-angiogenic agent |
| 03/20/2003 | US20030054556 Transfection compound for use as tool in the transfer of genetic material |
| 03/20/2003 | US20030054021 7-oxo-DHEA compounds for treating keratinous conditions/afflictions |
| 03/19/2003 | EP1292607A2 Novel solid body forms of mesoprogestin 11beta- 4e-(hydroxyiminomethyl)-phenyl]-17alpha-methoxymethyl-17beta-methoxy-estra-4,9-dien-3-one |
| 03/19/2003 | EP1056768B1 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 03/13/2003 | WO2003020214A2 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 03/13/2003 | WO2002042319A3 2-substituted estrogens as antiangiogenic agents |
| 03/13/2003 | US20030050286 Steroids with a cyclohexene moiety are oxidized to the corresponding alpha, beta-unsaturated ketone that is converted to the corresponding vicinal diol using a hydroborating reagent followed by oxidative workup |
| 03/12/2003 | CN1402734A 3-methylene steroid deriv. |
| 03/11/2003 | CA2099543C Photochemical labelling of nucleic acids with digoxigenin reagents and their use in gene probe test systems |
| 03/06/2003 | WO2003018603A1 Aminoglycoside lipid derivatives for transfection |
| 03/05/2003 | EP1288220A2 Neuroactive 3.alpha.-hydroxy-steroids of the androstane and pregnane series |
| 03/05/2003 | EP1287017A1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity |